HomeVYT • BME
add
Vytrus Biotech SA
Previous close
€17.50
Day range
€17.55 - €18.80
Year range
€2.86 - €18.80
Market cap
100.83M EUR
Avg Volume
12.34K
P/E ratio
48.12
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 2.33M | 52.57% |
Operating expense | 1.35M | 20.04% |
Net income | 727.35K | 185.08% |
Net profit margin | 31.19 | 86.88% |
Earnings per share | — | — |
EBITDA | 1.03M | 262.08% |
Effective tax rate | 4.36% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.44M | 36.01% |
Total assets | 14.66M | 31.72% |
Total liabilities | 4.35M | 13.44% |
Total equity | 10.31M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | 13.05% | — |
Return on capital | 16.56% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 727.35K | 185.08% |
Cash from operations | 1.08M | 77.71% |
Cash from investing | -924.84K | -212.00% |
Cash from financing | -105.61K | 31.45% |
Net change in cash | 45.48K | -70.66% |
Free cash flow | -163.46K | -356.93% |
About
Founded
2009
Website
Employees
44
